期刊文献+

多黏菌素耐药革兰阴性菌研究的文献计量分析 被引量:4

Bibliometric analysis of colistin resistant gram negative bacteria in research
原文传递
导出
摘要 目的 从文献计量学角度分析并了解多黏菌素耐药革兰阴性菌的耐药机制和耐药现状。方法 检索Pub Med、Em Base、Web of Science、中国知网、万方数据库中的相关文献,用Endnote X7软件去重、筛选,对纳入文献的外部特征及研究内容进行归纳及分析。结果 共纳入外文文献374篇、中文文献174篇。耐药率为0.1%~31.0%;耐药机制多为染色体介导,以外膜脂多糖修饰或丢失为主;2015年中国学者首次报道了质粒介导的新型耐药基因mcr-1。结论 革兰阴性菌对多黏菌素耐药率增长。 Objective To understand the current situation of resistance rate and mechanisms of colistin based on bibliometric approach. Methods All publications were searched on five databases (EmBase, PubMed, Web of Science, CNKI and Wanfang) and were screened by Endnote X7 software. Then eliminate and analysis was performed according to the external features of literature and research contents. Results A total of 374 international and 174 domestic literature papers were searched from databases. The rate of drug resistance was 0. 1% to 31.0%. The most studies of resistance mechanism was modification or loss of outer membrane lipopolysaccharide, a novel plasmid mediated resistant gene mcr - 1 was firstly reported by Chinese professors in 2015 year. Conclusion Colistin resistance rate is increasing.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2016年第17期1617-1620,共4页 The Chinese Journal of Clinical Pharmacology
基金 十二五国家重大科技专项基金资助项目(2012ZX09303004-002)
关键词 多黏菌素 耐药率 耐药机制 文献计量分析 colistin resistance rate resistance mechanism bibliometric analysis
  • 相关文献

参考文献22

  • 1OLAITAN A O, MORAND S, ROLAIN J M. Emergence of colistin - resistant bacteria in htm~s without colistin usage: a new worry and cause for vigilance [ J ]. lnt J Antimb:rob AgerUs, 2016, 47 ( 1 ) : 1 - 3.
  • 2LIU Y Y, WANG Y, WALSH T R, et al. Emergence of plasmid - mediated colistin resistance mechanism mcr - 1 in animals and hu- man beings in China: a microbiological and molecular biological study [J]. Lancet Inject Dis, 2016,16(2) :161 - 168.
  • 3SADER H S, FARRELL D J, CASTANHEIRA M, et al. Antimi- crobial activity of ceftolozane/tazobactam tested against Pseudo- monas aeruginosa and Enterobacteriaceae with various resistance patterns isolated in European hospitals (2011 - 12) [ J]. J Anti- microb Chemother, 2014, 69(10) :2713 -2722.
  • 4MONACO M, GIANI T, RAFFONE M, et al. Colistin resistance superimposed to endemic carhapenem - resistant Klebsiel/a pneutrmn- iae:a rapidly evolving problem in Italy, November 2013 to April 2014 [J]. Eur Surveill, 2014, 19(42) ;1 -5.
  • 5WETERINGS V,ZHOU K, ROSSEN J W, et al. An outbreak of eolistin - resistant KlebsieUa pneumoniae earbapenemase -produeing Klebsiella pneumoniae in the Netherlands ( July to December 2013 ) , with inter - institutional spread [J].Eur J Clin Microbiol Infect Dis ,2015, 34(8) :1647 - 1655.
  • 6PENA I, PICAZO J J, RODRIGUEZ - AVIAL C, et al. Carbape- nemase - producing Enterobaeteriaeeae in a tertiary hospital in Ma- drid, Spain : high percentage of eolistin resistance among VIM - 1 - producing KlebsieUa pneumoniae ST11 isolates [J].Int J Antimicrob Agents, 2014, 43(5) :460 -464.
  • 7ZILBERBERG M D, KLLEF O M H,SHORR A F. Acinetobacter baumannii resistance in respiratory and blood stream specimens in the United States, 2003 to 2012[J]. J Hosp Med, 2016, 11 ( 1 ) : 21 -26.
  • 8LEFBVRE B,LEVESQUE S, BOURGAULTA M, et al. Carbape- nem non- susceptible Enterobacteriaeeae in Quebec, Canada: re- sults of a laboratory surveillance program (2010 - 2012) [ J/OL]. PLoS Orte, 2015 -04 -24 [2016 -03 -05]. http://dx, doi. org/ 10. 1371/journal. pone. 0125076.
  • 9GALES A C, CASTANHEIRA M, JONES R N, et al. Antimierobi- al resistance among Gram - negative bacilli isolated from Latin A- merica: results from SENTRY Antimierobial Surveillance Program (Latin America, 2008 2010) [J]. Diagn Microbiol Infect Dis, 2012, 73(4) :354 -360.
  • 10MEZGHANI M S, REKIKM M, MAHJOUBI F, et al. Epidemiolo-gical study of Enterobacteriaceae resistance to colistin in Sfax ( Tuni- sia) [J]. Med Mal Infect, 2012, 42 (6) :256 -263.

二级参考文献55

  • 1Arias CA, Murray BE. Antibiotic-resistant bugs in the 21st century-a clinical super-challenge[J]. N Engl J Med, 2009, 360(5) : 439-443.
  • 2Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[S]. Tweenty-first in- formational supplement, 2011, M100-S21 Vol 31 No. 1.
  • 3Falagas ME, Giannopoulou KP, Kokolakis GN, et al. Fosfo- mycin: use beyond urinary tract and gastrointestinal infec tions[J]. Clin Infect Dis, 2008, 46(7): 1069-1077.
  • 4Olsson-Liljequist B, Burman LG. Introducing fosfomycin for surgical prophylaxis-emergence of resistance in aerobic faecal gram-negative bacteria of in patients, but not among strains causing infection after elective colorectal procedures [J ]. Scand J Infect Dis, 1993, 25(6) :725-733.
  • 5Andaker L, Burman LG, Eklund A, et al. Fosfomycin/met- ronidazole compared with doxycycline/metronidazole for the prophylaxis of infection after elective coloreetal surgery: a randomised double blind multicentre trial in 517 patients[J]. Eur J Surg, 1992, 158(3):181 185.
  • 6Nohr M, Andersen JC, Juul-Jensen KE. Prophylactic single dose fosfomycin and metronidazole compared with neomycin, haeitraein, metronidazole and ampicillin in elective colorectal operations[J]. Acta Chir Seand, 1990, 156(3):223-230.
  • 7Lindhagen J, Hadziomerovic A, Nordlung S, et al. Comparison of systemic prophylaxis with metronidazole-fosfomycin and met- ronidazole-cephalothin in elective colorectal surgery[J]. Acta Chir Scand, 1981, 147(4):277-283.
  • 8CLSI Performance standards for antimicrobial susceptibility testing[S]. Twenty second Informational supplement M100- S22 2012,32(3).
  • 9European Committee on Antimicrobial susceptibility testing, Breakpoint tables for interpretation of MICs and zone diame- ters[S]. Version 2, 2012, valid from 2012-01-01.
  • 10Bush K. Alarming β-lactamase mediated resistance in multi- drug-resistant Enterobacteraceae[J]. Curr Opinion Microbi- oh 2010, 13(5): 558-564.

共引文献1978

同被引文献17

引证文献4

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部